GSK plc to acquire RAPT Therapeutics Inc. for $58.00 per share, with an estimated upfront investment of $1.9 billion.

GSK plc GSK announced that it has entered into a definitive agreement to acquire California-based biotech RAPT Therapeutics ...

Bristol Myers Squibb BMY and GSK PLC GSK are among the largest global biopharma companies with broad and diverse portfolios.

GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly ...

GSK Deadline: Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights Rosen Law Firm, a global investor rights law firm ...

Shares of GSK PLC GSK rallied 1.90% to £18.52 Thursday, on what proved to be an all-around positive trading session for the ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire NEW YORK, March 8, 2025 NEW YORK, March 8, ...

Fintel reports that on November 7, 2025, JP Morgan Cazenove reiterated coverage of GSK plc - Depositary Receipt (NYSE:GSK) with a Underweight recommendation. As of October 30, 2025, the average ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best ...